Company Analysis

Sunshine Biopharma Inc. (SBFM)

Nasdaq: SBFM · Pharmaceutical Preparations · Fort Lauderdale, FL · filing with the SEC since 2007
Grade4.7
◀ Past 3.6● Present 5.8▶ Future 4.2
2 est.

Filings

266 filings since 2017 beside 40 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 99 days after the quarter ended. The proxy statement was last filed Nov 12, 2026.

Filings a yearinsider forms included
1920174633533157
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Aug 28, 2026.Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Sep 30, 2025.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Jun 7, 2024.SEC letters: 12 in the last 36 months, the newest May 18, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Aug 14, 2024.A late-filing notice, Form NT 10-Q, filed May 15, 2024.
Insider forms 40

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 DEF 14A Proxy statement Dec 29, 2026
Nov 10, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 27, 2026 DEF 14C Information statement Oct 30, 2026
Oct 14, 2026 SCHEDULE 13G Large holder notice
Oct 14, 2026 PRE 14C Preliminary information statement
Oct 14, 2026 8-K item 5.07 Shareholder vote · Current report Oct 13, 2026
Oct 13, 2026 SCHEDULE 13G Large holder notice
Oct 9, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Oct 8, 2026
Oct 9, 2026 424B4 Offering prospectus
Oct 7, 2026 EFFECT Registration effective
Oct 5, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 2, 2026 S-1 Listing registration
Sep 28, 2026 DEF 14C Information statement Sep 15, 2026
Sep 24, 2026 DRS Draft registration, confidential
Sep 16, 2026 PRE 14C Preliminary information statement Sep 15, 2026
Sep 16, 2026 8-K item 5.07 Shareholder vote · Current report Sep 15, 2026
Sep 11, 2026 8-K item 8.01 Other event · Current report
Sep 8, 2026 EFFECT Registration effective
Sep 8, 2026 424B3 Shelf offering
Aug 28, 2026 S-1 Listing registration
Aug 28, 2026 8-K item 5.02 Officer or director change · Current report Aug 25, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 3, 2026 8-K item 8.01 Other event · Current report
Jul 20, 2026 424B5 Shelf offering
Jul 20, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Jul 10, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jul 8, 2026
Jul 8, 2026 SCHEDULE 13G Large holder notice
Jun 8, 2026 DEF 14C Information statement
May 29, 2026 PRE 14C Preliminary information statement
May 29, 2026 8-K item 5.07 Shareholder vote · Current report May 28, 2026
May 22, 2026 SCHEDULE 13G Large holder notice
May 21, 2026 SCHEDULE 13G Large holder notice
May 19, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report May 18, 2026
May 19, 2026 424B4 Offering prospectus
May 18, 2026 EFFECT Registration effective
May 18, 2026 CORRESP Reply to the SEC
May 18, 2026 CORRESP Reply to the SEC
40 of 266 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton SBFM · research, not advice